Harold H. Shlevin's most recent trade in Galectin Therapeutics Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.98 per share. | 17 Dec 2025 | 20,000 | 31,206 (0%) | 0% | 2.0 | 39,600 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 7.04 per share. | 17 Dec 2025 | 19,793 | 11,206 (0%) | 0% | 7.0 | 139,303 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 7.04 per share. | 17 Dec 2025 | 4,706 | 6,500 (0%) | 0% | 7.0 | 33,121 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 6.27 per share. | 12 Dec 2025 | 19,793 | 11,206 (0%) | 0% | 6.3 | 124,181 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.16 per share. | 12 Dec 2025 | 19,793 | 30,999 (0%) | 0% | 4.2 | 82,339 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 19,793 | 53,417 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.16 per share. | 12 Dec 2025 | 8,417 | 19,623 (0%) | 0% | 4.2 | 35,015 | Common Stok |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 8,417 | 0 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 12 Dec 2025 | 8,417 | 11,206 (0%) | 0% | 6.3 | 53,027 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 35,000 | 35,000 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 6.02 per share. | 08 Dec 2025 | 35,000 | 11,206 (0%) | 0% | 6.0 | 210,665 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 08 Dec 2025 | 35,000 | 46,206 (0%) | 0% | 2.1 | 73,850 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 5.95 per share. | 08 Dec 2025 | 35,000 | 11,206 (0%) | 0% | 6.0 | 208,250 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.86 per share. | 08 Dec 2025 | 35,000 | 46,206 (0%) | 0% | 2.9 | 100,100 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 5.95 per share. | 08 Dec 2025 | 25,000 | 11,206 (0%) | 0% | 5.9 | 148,650 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.72 per share. | 08 Dec 2025 | 25,000 | 36,206 (0%) | 0% | 1.7 | 43,000 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 20,000 | 20,000 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 20,000 | 20,000 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 08 Dec 2025 | 20,000 | 11,206 (0%) | 0% | 6.0 | 120,040 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 08 Dec 2025 | 20,000 | 31,206 (0%) | 0% | 1.1 | 22,200 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 5.96 per share. | 08 Dec 2025 | 20,000 | 11,206 (0%) | 0% | 6.0 | 119,240 | Common stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.98 per share. | 08 Dec 2025 | 20,000 | 31,206 (0%) | 0% | 2.0 | 39,600 | Common stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 5.96 per share. | 08 Dec 2025 | 20,000 | 11,206 (0%) | 0% | 6.0 | 119,240 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 08 Dec 2025 | 20,000 | 31,206 (0%) | 0% | 2.1 | 42,200 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 16,790 | 73,210 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 6.27 per share. | 08 Dec 2025 | 16,790 | 11,206 (0%) | 0% | 6.3 | 105,206 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.16 per share. | 08 Dec 2025 | 16,790 | 27,996 (0%) | 0% | 4.2 | 69,846 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 08 Dec 2025 | 4,000 | 11,206 (0%) | 0% | 6.0 | 24,020 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Shlevin H. Harold | Director | Purchase of securities on an exchange or from another person at price $ 1.16 per share. | 30 Dec 2024 | 6,500 | 15,206 (0%) | 0% | 1.2 | 7,540 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 70,000 | 70,000 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 40,000 | 40,000 | - | - | Stock option (right to buy) |